Idexx Laboratories Thereafter decreased by 19.3% to $34.89M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.8%, from $38.68M to $34.89M.
other_lessee_operating_lease_liability_to_be_paid_after__90ad44| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $47.11M | $48.99M | $45.98M | $54.12M | $53.81M | $52.20M | $52.71M | $54.30M | $48.11M | $49.18M | $52.01M | $38.68M | $42.68M | $43.25M | $34.89M |
| QoQ Change | — | +4.0% | -6.1% | +17.7% | -0.6% | -3.0% | +1.0% | +3.0% | -11.4% | +2.2% | +5.8% | -25.6% | +10.3% | +1.3% | -19.3% |
| YoY Change | — | — | — | +14.9% | +9.8% | +13.5% | -2.6% | +0.9% | -7.8% | -6.7% | -4.2% | -19.6% | -13.2% | -16.8% | -9.8% |